Details for New Drug Application (NDA): 091211
✉ Email this page to a colleague
The generic ingredient in ATOVAQUONE AND PROGUANIL HYDROCHLORIDE is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
Summary for 091211
| Tradename: | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE |
| Applicant: | Glenmark Pharms Ltd |
| Ingredient: | atovaquone; proguanil hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 091211
| Mechanism of Action | Dihydrofolate Reductase Inhibitors |
Suppliers and Packaging for NDA: 091211
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | atovaquone; proguanil hydrochloride | TABLET;ORAL | 091211 | ANDA | Proficient Rx LP | 63187-879 | 63187-879-16 | 16 TABLET, FILM COATED in 1 BOTTLE (63187-879-16) |
| ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | atovaquone; proguanil hydrochloride | TABLET;ORAL | 091211 | ANDA | Proficient Rx LP | 63187-879 | 63187-879-24 | 24 TABLET, FILM COATED in 1 BOTTLE (63187-879-24) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG;100MG | ||||
| Approval Date: | Jan 12, 2011 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 62.5MG;25MG | ||||
| Approval Date: | Apr 6, 2015 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
